SHOULD EVERYONE BE TAKING OZEMPIC? DOCTORS SAY MORE PEOPLE COULD BENEFIT

Summary from the TLDR newsletter

The number of diseases that the GLP-1 category of drugs seems to be effective in treating is expanding rapidly. The drug could be beneficial to a third to a majority of adults. Many of the proven and potential benefits of the drugs cascade from their effect on obesity, but some are independent of weight loss, possibly from the anti-inflammatory effects of the drugs.